AFF3 maintains metabolic quiescence in naive CD8 T cells and prevents premature immune aging
JCI Insight · 10.08.2026 · 11 (15)
DOI: 10.1172/jci.insight.207387 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 23.06.2026. Verfasst von Molly E Lumnitzer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, IU Cooperative Center of Excellence in Hematology, and. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Aging, Premature, Aging, DNA-Binding Proteins. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
It is necessary for naive CD8 T cells to be actively maintained in a quiescent metabolic state in order to respond robustly to infection while avoiding inappropriate activation during homeostasis. With age, this quiescent state is lost and the CD8 T cell response to infection decreases. The factors regulating metabolic quiescence of CD8 T cells and how this regulation is lost during aging are not completely understood. Herein, we identify the transcription factor AFF3 as a regulator of metabolic quiescence in naive CD8 T cells. While naive AFF3-deficient CD8 T cells are more metabolically active prior to infection, they have reduced accumulation in response to viral infection, and this is correlated with a poor capacity to engage glycolysis. During aging in both murine and human CD8 T cells, AFF3 expression is decreased. In mice, this is associated with a loss of metabolic quiescence and reduced capacity to accumulate following infection. Our data highlight the role of metabolic regulation in CD8 T cell quiescence and identify a transcription factor that may be a target to reinvigorate CD8 T cell responses during aging. AFF3 is important to the function of cytotoxic T cells by regulating their metabolism. This protein is also important to prevent premature immune aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, IU Cooperative Center of Excellence in Hematology, and.
- IU Melvin and Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine (IUSM), Indianapolis, Indiana, USA.
- Département de Microbiologie, Immunologie et Infectiologie, Université de Montréal, Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, Quebec, Canada.
- Rosalind and Morris Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada.
- Department of Anatomy, Cell Biology & Physiology.
- Department of Medicine, and.
Förderung
- Wellcome Trust
- NCI NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
Zitieren
APA
Lumnitzer, M. E., Valbon, S. F., Condotta, S. A., Norlander, A. E., Liu, S., Wan, J., & Richer, M. J. (2026). AFF3 maintains metabolic quiescence in naive CD8 T cells and prevents premature immune aging. JCI Insight, 11(15). https://doi.org/10.1172/jci.insight.207387
Vancouver
Lumnitzer ME, Valbon SF, Condotta SA, Norlander AE, Liu S, Wan J, et al. AFF3 maintains metabolic quiescence in naive CD8 T cells and prevents premature immune aging. JCI Insight. 2026;11(15). doi:10.1172/jci.insight.207387
BibTeX
@article{Lumnitzer2026,
author = {Lumnitzer, Molly E and Valbon, Stefanie F and Condotta, Stephanie A and Norlander, Allison E and Liu, Sheng and Wan, Jun and Richer, Martin J},
title = {AFF3 maintains metabolic quiescence in naive CD8 T cells and prevents premature immune aging},
journal = {JCI Insight},
year = {2026},
volume = {11},
number = {15},
doi = {10.1172/jci.insight.207387}
}
EUVIMED